CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma

CD19 and CD30 CAR T-Cell Immunotherapy for High-Risk Classical Hodgkin’s Lymphoma

BackgroundIn clinical applications of CAR T-cell therapy, life-threatening adverse events including cytokine release syndrome and neurotoxicity can lead to treatment failure. Outcomes of patients treated with anti-CD30 CAR T- cell have been disappointing in relapsing/refractory (r/r) classical Hodgk...

Full description

Bibliographic Details
Main Authors:	YuanBo Xue, Xun Lai, RuiLei Li, ChunLei Ge, BaoZhen Zeng, Zhen Li, QiaoFen Fu, LiuFang Zhao, SuWei Dong, JinYan Yang, JiYin Guo, QingYin Meng, QingHua Tan, ZhenHui Li, HaiYan Ding, YanLei Zhang, ShaoHui Liu, Alex H. Chang, Hong Yao, RongCheng Luo
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-02-01
Series:	Frontiers in Oncology
Subjects:	immunotherapy classical Hodgkin’s lymphoma (cHL) CD19 CD30 chimeric antigen receptor (CAR) T-cell
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2020.607362/full

Similar Items

The role of CD68+ macrophage in classical Hodgkin lymphoma patients from Egypt
by: Osama Mohamed, et al.
Published: (2020-02-01)

HLA Expression in Relation to HLA Type in Classic Hodgkin Lymphoma Patients
by: Geok Wee Tan, et al.
Published: (2021-11-01)

Clinico-pathological significance of immunohistochemically marked tumor-associated macrophage in classic Hodgkin lymphoma
by: Mona Y. Y. Abd Allah, et al.
Published: (2020-04-01)

Management of classical Hodgkin lymphoma: a look at up to date evidence and current treatment approaches
by: Walter Hanel, et al.
Published: (2022-12-01)

Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
by: Xiao‐bo Ma, et al.
Published: (2018-09-01)

Differential Expression of CD45RO and CD45RA in Bovine T Cells
by: Anmol Kandel, et al.
Published: (2022-06-01)

CD39 expression defines exhausted CD4+ T cells associated with poor survival and immune evasion in human gastric cancer
by: Zhen‐quan Duan, et al.
Published: (2024-01-01)

What Else Can CD39 Tell Us?
by: Hai Zhao, et al.
Published: (2017-06-01)

CD39hi identifies an exhausted tumor-reactive CD8+ T cell population associated with tumor progression in human gastric cancer
by: Yang Shen, et al.
Published: (2024-04-01)

Cd248a and Cd248b in zebrafish participate in innate immune responses
by: Xianpeng Li, et al.
Published: (2022-08-01)

The value of changes in CD8+CD28+ and CD4+CD28+ cells in patients with HIV infection concurrent with tuberculosis during treatment
by: A A Popova, et al.
Published: (2013-11-01)

Clinical symptoms and immune injury reflected by low CD4/CD8 ratio should increase the suspicion of HIV coinfection with tuberculosis
by: Li Li, et al.
Published: (2023-03-01)

Skewed CD39/CD73/adenosine pathway in B cells is associated with innate immune hyperactivation in chronic HIV-1 infection
by: Wen-Xian Chang, et al.
Published: (2019-02-01)

Level of Foxp3, DNMTs, methylation of Foxp3 promoter region, and CD4 + CD25 + CD127low regulatory T cells in vulvar lichen sclerosus
by: Lin Wang, et al.
Published: (2021-06-01)

The Tumor Suppressive mir-148a Is Epigenetically Inactivated in Classical Hodgkin Lymphoma
by: Julia Paczkowska, et al.
Published: (2020-10-01)

Controllable Synthesis of Single-Crystalline CdO and Cd(OH)<sub>2</sub>Nanowires by a Simple Hydrothermal Approach
by: Au Chaktong, et al.
Published: (2010-01-01)

Clinical Significance of BTLA, CD27, CD70, CD28 and CD80 as Diagnostic and Prognostic Markers in Ovarian Cancer
by: Janina Świderska, et al.
Published: (2022-01-01)

Improved photoluminescence quantum yield and stability of CdSe-TOP, CdSe-ODA-TOPO, CdSe/CdS and CdSe/EP nanocomposites
by: Shutian Wei, et al.
Published: (2016-01-01)

CD3+CD4+CD8+ T-LYMPHOCYTES COUNT IN PROGNOSIS OF EARLY KIDNEY ALLOGRAFT DYSFUNCTION
by: Zybleva S. V., et al.
Published: (2020-03-01)

Evaluation of Mycobacterium tuberculosis specific antigen-stimulated CD27−CD38+IFN-γ+CD4+ T cells for discrimination of active tuberculosis
by: Yong Fang, et al.
Published: (2022-12-01)

Current and Future Developments in the Treatment of CD30+ Lymphomas
by: Lena Specht, et al.
Published: (2015-11-01)

Immunohistochemical Evaluation of CD3, CD4, CD8, and CD20 in Decidual and Trophoblastic Tissue Specimens of Patients with Recurrent Pregnancy Loss
by: Dimitrios Kavvadas, et al.
Published: (2022-02-01)

Immune profiling identifies CD8+ T-cell subset signatures as prognostic markers for recurrence in papillary thyroid cancer
by: Zhen Chen, et al.
Published: (2022-11-01)

HIV Reservoir Decay and CD4 Recovery Associated With High CD8 Counts in Immune Restored Patients on Long-Term ART
by: Lu-Xue Zhang, et al.
Published: (2020-07-01)

Molecular and Functional Analyses of the Primordial Costimulatory Molecule CD80/86 and Its Receptors CD28 and CD152 (CTLA-4) in a Teleost Fish
by: Tao-Zhen Lu, et al.
Published: (2022-06-01)

Progress of CD8+CD25+regulatory T cells in diseases
by: WEN Li-na, CHEN Li, DUAN Rui, LI Fang
Published: (2022-12-01)

On the structural evolutionary behavior of the CdTe/HgCdTe interface during the annealing process
by: Jiyuan Chen, et al.
Published: (2024-01-01)

CD8 and CD4 T Cell Populations in Human Kidneys
by: Carlos van der Putten, et al.
Published: (2021-02-01)

Quantitative flow cytometric evaluation of CD200, CD123, CD43 and CD52 as a tool for the differential diagnosis of mature B-cell neoplasms
by: Elissandra Machado Arlindo, et al.

Unbalanced expression of aryl hydrocarbon receptor in peripheral blood CCR6+CD4+ and CD4+CD25+T cells of rheumatoid arthritis
by: Lin Cheng, et al.

Sel T Regulator CD4+CD25+ Mencegah Terjadinya Fenotip Letal pada Mencit Defisiensi CD122
by: Muhaimin Rifa’i, et al.
Published: (2012-11-01)

Changes of Mycobacterium tuberculosis specific antigen-stimulated CD27−CD38+IFN-γ+CD4+ T cells before and after anti-tuberculosis treatment
by: Yong Fang, et al.
Published: (2024-03-01)

High Levels of CD244 Rather Than CD160 Associate With CD8+ T-Cell Aging
by: Xinyue Wang, et al.
Published: (2022-03-01)

Role of the CD40–CD40L expression level pathway in the diagnosis of unexplained recurrent pregnancy loss
by: Hui Ding, et al.
Published: (2023-12-01)

The association between the CD4/CD8 ratio and surgical site infection risk among HIV-positive adults: insights from a China hospital
by: Bo Liu, et al.
Published: (2023-07-01)

Cytokine-Induced Killer Cells Express CD39, CD38, CD203a, CD73 Ectoenzymes and P1 Adenosinergic Receptors
by: Alberto L. Horenstein, et al.
Published: (2018-04-01)

Distribution and clinical significance of circulating CD8+CD28− regulatory T cells in the peripheral blood of patients with pulmonary tuberculosis
by: Xin Yu, et al.
Published: (2022-07-01)

Impact of Tumour Epstein–Barr Virus Status on Clinical Outcome in Patients with Classical Hodgkin Lymphoma (cHL): A Review of the Literature and Analysis of a Clinical Trial Cohort of Children with cHL
by: Mahdi Nohtani, et al.
Published: (2022-09-01)

The Effect of CdCl2 and annealing treatments on structural properties of CdS/CdTe heterojunction
by: Muhammad A. Razooqi
Published: (2011-01-01)

Coexpresión de CD4 y CD8 en linfocitos de sangre periférica en pacientes positivos para VIH Peripheral blood lymphocyte CD4 and CD8 co-expression in HIV positive patients
by: Alberto Gómez, et al.
Published: (2008-12-01)